The first meeting of the Advisory Committee on Immunization Practices (ACIP) under new Secretary Robert F. Kennedy Jr. proceeded as usual, with members voting to expand vaccine options and lower age recommendations for certain vaccines. Despite concerns about potential interference, the committee followed its typical format, reviewing data and modeling for various vaccines.
Committee members previewed topics such as flu and COVID-19 vaccines that will be considered in future meetings. However, some nuances reflected changes made by the Trump administration, including deep cuts to funding and resources for public health. The impact of these cuts was evident during the meeting, with technical issues and a reduced staff affecting the proceedings.
Dr. Tracy Beth Høeg, a new FDA representative on the committee, raised concerns about vaccine safety, citing biases in estimates. CDC staff responded that their studies are designed to account for such biases, but some questioned whether this is enough to ensure accurate recommendations.
In contrast, public comments expressed support for the ACIP’s work, praising its role in ensuring evidence-based vaccine recommendations. The meeting marked a renewed focus on transparency and accountability, following a postponement due to concerns about potential interference.
Source: https://www.npr.org/sections/shots-health-news/2025/04/16/nx-s1-5366868/cdc-vaccine-meeting-rfk